4 hours agoDenmark joins five EU states, suspends Kosovo's expected vaccine
Periskopi(5 years ago)
(5 years ago)Denmark has decided to suspend the use of the company's vaccine “AstraZeneca” against the Devi-19 disease after presenting blood coagulating cases, thus joining five other European Union states that have already made the same decision. Denmark's Health Minister Magnus Heunique stated: “currently cannot [...]
Denmark's Health Minister Magnus Heunicke stated: “currently cannot be reached at any conclusion if there is any connection. We are acting early, this should be thoroughly investigated”, the Daily Mail writes.
Earlier, the decision to suspend the use of “AstraZeneca” has also been made by Austria, Luxembourg, Estonia, Lithuania and Latvia.
This decision was made by EU countries despite the fact that the European drug regulator has said that according to preliminary research, the vaccine group in Austria is unlikely to have been linked to the death of a 49-year-old nurse who received the Astra-Zeneca vaccine.
With this vaccine, which will be produced by the “Serum” in India, Kosovo is expected to be supplied, but it is not known when exactly the first doses will reach. These doses in Kosovo are expected to arrive as part of the COVAX programme.
The nurse died in Austria from multiple blood clots in blood vessels ten days after being vaccinated, the European Drug Agency reported.
Another patient was diagnosed with pulmonary embolism, which produces blockades in lung arteries, but her condition is improving.
By Tuesday, two more cases of coagulating patients have been identified by the group that received the same doses of vaccines.
The European agency said that for now there is no evidence that vaccine has caused these health problems in patients, and that thrombosis is not on the list of possible side effects of the vaccine.
According to the agency, part of the vaccine group used in Austria is one million doses that have been distributed into 17 European Union states.
